Clinical Trials Directory

Trials / Terminated

TerminatedNCT03091855

PLUG Dementia Trial and MRI PLUG Dementia Sub-Study

Overall and MRI-based Impact of Percutaneous Left Atrial Appendage Closure on the Cognitive Decline and Dementia in Patients With Atrial Fibrillation (PLUG Dementia Trial and MRI PLUG Dementia Sub-Study)

Status
Terminated
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

PLUG Dementia Trial: Patients will be screened at Intermountain Medical Center and at Intermountain affiliated anticoagulation clinics in the Salt Lake City region. Patients with atrial fibrillation that undergo a standard of care, clinically approved, left atrial appendage closure will be considered for study. All patients will be followed for 24 months, and will be assessed at the 3-, 6-, 12-, 18- and 24-months post-left atrial appendage closure as well as other visits deemed necessary for clinical care. All subjects will undergo protocol-specified laboratory tests and will complete 6 standard, validated questionnaires at each follow-up visit, except at the 3-month visit when only one questionnaire will be administered. A subset of patients (n=20), will receive a cranial MRI at baseline and 24-month visit. MRI PLUG Dementia Sub-Study: In addition to the above, 20 of the 60 subjects who are selected for participation in this sub-study will receive a cranial MRI at baseline and at the 2-year (24 months) follow-up visit.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireAlzheimer's Disease Assessment Scale (ADAS-cog11) and Disability Assessment for Dementia (DAD) Questionnaires
DIAGNOSTIC_TESTMagnetic Resonance ImagingMRI at baseline and at 24 months post-enrollment for 20 sub-study participants

Timeline

Start date
2017-04-03
Primary completion
2021-01-08
Completion
2021-01-08
First posted
2017-03-27
Last updated
2021-04-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03091855. Inclusion in this directory is not an endorsement.